User profiles for Carles Villabona

Carlos Villabona

medico Universidad Barcelona
Verified email at comb.cat
Cited by 1529

[PDF][PDF] Tratamiento de la hiponatremia secundaria al síndrome de secreción inadecuada de la hormona antidiurética: algoritmo multidisciplinar

I Runkle, C Villabona, A Navarro, A Pose… - Nefrología …, 2014 - SciELO Espana
Introducción: El síndrome de secreción inadecuada de la hormona antidiurética (SIADH) es
la causa más frecuente de hiponatremia en el paciente hospitalizado. Sin embargo, faltan …

El tratamiento de la hiponatremia secundaria al síndrome de secreción inadecuada de la hormona antidiurética

I Runkle, C Villabona, A Navarro, A Pose, F Formiga… - Medicina Clínica, 2013 - Elsevier
El síndrome de secreción inadecuada de la hormona antidiurética (SIADH) es la causa más
frecuente de hiponatremia en el paciente hospitalizado. Sin embargo, faltan protocolos y …

Association of both Langerhans cell histiocytosis and Erdheim-Chester disease linked to the BRAFV600E mutation

…, A Néel, F Lifermann, C Villabona… - Blood, The Journal …, 2014 - ashpublications.org
Histiocytoses are a group of heterogeneous diseases that mostly comprise Langerhans cell
histiocytosis (LCH) and non-LCH. The association of LCH with non-LCH is exceptional. We …

Blood volumes and renal function in overt and subclinical primary hypothyroidism

C Villabona, M Sahun, N Gómez, JM Gómez… - The American journal of …, 1999 - Elsevier
Introduction Thyroid dysfunction is associated with marked alterations in cardiovascular and
renal functions. In hypothyroidism, myocardial contractility, cardiac output, and oxygen …

[HTML][HTML] Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome

J Joven, C Villabona, E Vilella, L Masana… - … England Journal of …, 1990 - Mass Medical Soc
Background and Methods. Patients with the nephrotic syndrome characteristically have
multiple abnormalities of lipoprotein metabolism, but the cause and exact nature of these …

Changes in acromegaly treatment over four decades in Spain: analysis of the Spanish Acromegaly Registry (REA)

…, R García, R Cámara, I Bernabeu, A Soto, C Villabona… - Pituitary, 2013 - Springer
Since 1997 there is an online National Registry of acromegalic patients in Spain (REA). We
aimed to study changes in acromegaly treatment and outcomes over the last four decades in …

Molecular profiling for acromegaly treatment: a validation study

…, C Del Pozo, G Obiols, C Villabona… - Endocrine-Related …, 2020 - erc.bioscientifica.com
Pharmacologic treatment of acromegaly is currently based upon assay-error strategy, the
first-generation somatostatin receptor ligands (SRL) being the first-line treatment. However, …

Guía clínica de manejo de la diabetes insípida y del síndrome de secreción inapropiada de hormona antidiurética en el postoperatorio de la cirugía hipofisaria

C Lamas, C del Pozo, C Villabona - Endocrinología y Nutrición, 2014 - Elsevier
Las alteraciones en el metabolismo del agua y en la regulación de la vasopresina (AVP) u
hormona antidiurética (ADH) son complicaciones frecuentes de la cirugía hipofisaria. La …

[HTML][HTML] Data mining analyses for precision medicine in acromegaly: a proof of concept

…, T Sardon, A Simó-Servat, B Biagetti, C Villabona… - Scientific Reports, 2022 - nature.com
Predicting which acromegaly patients could benefit from somatostatin receptor ligands (SRL)
is a must for personalized medicine. Although many biomarkers linked to SRL response …

Prevalence, clinical features, and natural history of incidental clinically non-functioning pituitary adenomas

…, P García-Sancho, JJ Díez, C Villabona… - Hormone and …, 2017 - thieme-connect.com
The objective of the study was to assess the prevalence and clinical features of incidentally
discovered clinically non-functioning pituitary adenoma (CNFPA) and to analyze its natural …